Catalyst

Catalyst is a prominent Israeli venture capital firm with over 24 years of experience in investing in mature, disruptive technology companies that have an Israel nexus. Established in 1999, it is currently the only fund still operating with the same managing partners. Catalyst recently announced the closing of Catalyst IV Fund, which will manage assets of $150 million. The new fund, which has already invested in 3 companies – Curalife, Addionics, and Nexar – will invest in growth companies in various sectors including Cybersecurity, Life Sciences, DeepTech, Mobility, Climatech, Foodtech, and Renewable Energy. Catalyst Funds have a total of $450 million in managed assets. Catalyst III resulted in five exits out of eight investments, with four going public in America and one through M&A.

The partners in Catalyst are Edouard Cukierman, Yair Shamir, Boaz Harel, Lisya Bahar-Manoah, and Luc Muller. They have a proven track record of supporting the next generation of entrepreneurs and innovators in Israel. Catalyst's investment strategy focuses on identifying and nurturing companies with strong technological foundations, clear regulatory pathways, and scalable business models.

With a deep network in the Israeli technology ecosystem, Catalyst provides its portfolio companies with strategic guidance, industry expertise, and access to a broad network of potential partners and customers. The firm's hands-on approach aims to drive innovation and fundamentally transform patient outcomes in the healthcare sector, among other industries.